and graphical testing procedure are provided in the Supplementary Appendix. From December 2016 through December 2020, a total of 227 youths with type 2 diabetes were assessed for eligibility.

In patients with type 2 diabetes who were receiving metformin, the novel once-weekly dual glucose-dependent insulinotropic polypeptide–GLP-1 receptor agonist tirzepatide was noninferior and ...

Additionally, six embecta-sponsored abstracts focusing on injection ... among the extensive treatment options available for type 2 diabetes (T2D). Through a series of presentations and a panel ...

Eligibility criteria for selecting studies We included cohort studies that explored the association between walking speed and the risk of type 2 diabetes in adults ... search and screened the titles ...